Status: retired, Primitive. Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3689759014 | Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
3689760016 | Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem (as imipenem monohydrate) 500 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Is a | Cilastatin and imipenem only product in parenteral dose form | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Plays role | Antibacterial therapeutic role | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Is a | Cilastatin- and imipenem-containing product | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has active ingredient | Beta-lactam antibacterial | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has active ingredient | Carbapenem | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has active ingredient | Cilastatin | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has active ingredient | Imipenem | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has manufactured dose form | Powder for suspension for injection | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Is a | Cilastatin- and imipenem-containing product in parenteral dose form | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has BoSS | Imipenem | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 1 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has BoSS | Cilastatin | false | Inferred relationship | Some | 1 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength numerator value | 500 | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has unit of presentation | Vial | false | Inferred relationship | Some | ||
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has precise active ingredient | Imipenem monohydrate | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has precise active ingredient | Cilastatin sodium | false | Inferred relationship | Some | 1 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength denominator unit | Vial | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
Cilastatin (as cilastatin sodium) 500 mg and imipenem (as imipenem monohydrate) 500 mg powder for suspension for injection vial | Has presentation strength denominator unit | Vial | false | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set